Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 13 studies | 26% ± 8% | |
pericyte | 9 studies | 22% ± 5% | |
fibroblast | 7 studies | 22% ± 5% | |
ciliated cell | 6 studies | 27% ± 6% | |
ionocyte | 4 studies | 25% ± 2% | |
pancreatic A cell | 4 studies | 32% ± 19% | |
connective tissue cell | 4 studies | 26% ± 9% | |
epithelial cell | 4 studies | 25% ± 8% | |
cardiac muscle cell | 4 studies | 27% ± 8% | |
type II pneumocyte | 3 studies | 29% ± 6% | |
astrocyte | 3 studies | 23% ± 2% | |
renal alpha-intercalated cell | 3 studies | 40% ± 2% | |
myofibroblast cell | 3 studies | 21% ± 2% | |
endothelial cell | 3 studies | 24% ± 3% | |
hepatocyte | 3 studies | 45% ± 28% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 97% | 3474.34 | 237 / 245 | 99% | 265.80 | 497 / 502 |
liver | 100% | 8355.13 | 225 / 226 | 92% | 123.40 | 374 / 406 |
adrenal gland | 100% | 6027.60 | 258 / 258 | 91% | 116.03 | 209 / 230 |
pancreas | 91% | 2020.51 | 300 / 328 | 84% | 33.67 | 149 / 178 |
brain | 59% | 762.19 | 1564 / 2642 | 96% | 146.04 | 680 / 705 |
breast | 80% | 1086.46 | 369 / 459 | 69% | 35.02 | 771 / 1118 |
uterus | 94% | 2648.06 | 160 / 170 | 50% | 28.16 | 228 / 459 |
ovary | 97% | 3262.64 | 175 / 180 | 46% | 11.40 | 197 / 430 |
lung | 81% | 1206.54 | 468 / 578 | 57% | 27.74 | 661 / 1155 |
intestine | 81% | 1018.88 | 784 / 966 | 55% | 19.91 | 289 / 527 |
bladder | 90% | 1399.95 | 19 / 21 | 43% | 15.33 | 215 / 504 |
thymus | 77% | 946.27 | 500 / 653 | 57% | 24.92 | 342 / 605 |
stomach | 89% | 1623.87 | 320 / 359 | 43% | 15.29 | 124 / 286 |
kidney | 82% | 907.87 | 73 / 89 | 32% | 21.26 | 285 / 901 |
heart | 94% | 6288.11 | 811 / 861 | 0% | 0 | 0 / 0 |
esophagus | 71% | 2612.38 | 1027 / 1445 | 21% | 7.03 | 39 / 183 |
blood vessel | 92% | 6009.29 | 1232 / 1335 | 0% | 0 | 0 / 0 |
muscle | 91% | 3522.21 | 734 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 37.40 | 23 / 29 |
skin | 64% | 979.39 | 1160 / 1809 | 13% | 4.24 | 61 / 472 |
adipose | 62% | 707.73 | 744 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 44% | 18.10 | 20 / 45 |
peripheral blood | 39% | 837.76 | 363 / 929 | 0% | 0 | 0 / 0 |
spleen | 9% | 95.27 | 22 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.73 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0030154 | Biological process | cell differentiation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_1900745 | Biological process | positive regulation of p38MAPK cascade |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | GADD45G |
Protein name | GADD45G protein Growth arrest and DNA damage-inducible protein GADD45 gamma (Cytokine-responsive protein CR6) (DNA damage-inducible transcript 2 protein) (DDIT-2) Growth arrest and DNA-damage-inducible gamma Growth arrest and DNA damage inducible gamma |
Synonyms | CR6 DDIT2 |
Description | FUNCTION: Involved in the regulation of growth and apoptosis. Mediates activation of stress-responsive MTK1/MEKK4 MAPKKK. |
Accessions | ENST00000252506.11 ENST00000375769.1 Q5VZ88 Q6IAW6 Q5MAI3 O95257 |